Clover Biopharmaceuticals (HKSE:02197) EBIT per Share : HK$-0.76 (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clover Biopharmaceuticals EBIT per Share?

Clover Biopharmaceuticals's EBIT per Share for the six months ended in Dec. 2024 was HK$-0.69. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.76.

During the past 3 years, the average EBIT per Share Growth Rate was 67.00% per year. During the past 5 years, the average EBIT per Share Growth Rate was -30.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Clover Biopharmaceuticals's EBIT per Share or its related term are showing as below:

HKSE:02197' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -247.4 Med: -38.1 Max: 67
Current: 67

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Clover Biopharmaceuticals was 67.00% per year. The lowest was -247.40% per year. And the median was -38.10% per year.

HKSE:02197's 3-Year EBIT Growth Rate is ranked better than
96.44% of 1237 companies
in the Biotechnology industry
Industry Median: 8.1 vs HKSE:02197: 67.00

Clover Biopharmaceuticals's EBIT for the six months ended in Dec. 2024 was HK$-861.50 Mil.

Clover Biopharmaceuticals EBIT per Share Historical Data

The historical data trend for Clover Biopharmaceuticals's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Biopharmaceuticals EBIT per Share Chart

Clover Biopharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-0.93

-15.94

-2.48

-0.11

-0.76

Clover Biopharmaceuticals Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT per Share	Get a 7-Day Free Trial					-1.31	0.58	-0.69	-0.08	-0.69

Clover Biopharmaceuticals EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Clover Biopharmaceuticals's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-958.419	/	1253.673
=	-0.76

Clover Biopharmaceuticals's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-861.495	/	1255.396
=	-0.69

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.76

Clover Biopharmaceuticals (HKSE:02197) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Clover Biopharmaceuticals EBIT per Share Related Terms

Thank you for viewing the detailed overview of Clover Biopharmaceuticals's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Clover Biopharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clover Biopharmaceuticals Ltd (HKSE:02197) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 758 West Nanjing Road, Room 1901, Jing’an District, Shanghai, CHN

Website

https://www.cloverbiopharma.com

Clover Biopharmaceuticals Ltd is a clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutic candidates for infectious diseases as well as cancer and autoimmune diseases.

Executives

Liang Peng	2101 Beneficial owner
Liang Joshua G	2501 Other
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager
Aut-xxi Investment Holdings Limited	2201 Interest of corporation controlled by you
Jnry V Holdings Limited	2101 Beneficial owner
Aut-xxi Hk Holdings Limited	2101 Beneficial owner
Aut-xxi Holdings Limited	2201 Interest of corporation controlled by you
Hh Imv Holdings, L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Temasek Holdings (private) Limited	2201 Interest of corporation controlled by you
The Core Trust Company Limited	2301 Trustee
Tct (bvi) Limited	2501 Other
Super Novel International Limited	2306 Nominee for another person
Shang Hai Tian He Sheng Tai Qi Ye Guan Li He Huo Qi Ye You Xian He Huo

Clover Biopharmaceuticals Headlines

No Headlines